Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03129880 · ClinicalTrials.gov registry record · NA
Intensive Versus Traditional Voice Therapy
A NA study of Dysphonia, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03129880: Completed NA study of Dysphonia, sponsored by University of Wisconsin, Madison.
NCT03129880 is a NA study of Dysphonia that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03129880, a NA study of Dysphonia, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if there are differences in treatment outcomes between traditional voice therapy, performed weekly for a maximum of 6 weeks versus intensive voice therapy, consisting of 4-6 therapy sessions performed within one day.
Primary Outcome
Pre to Post difference in participant's self-efficacy for voice practice and healthy voice technique between therapy groups and within subsets of subjects - readiness ruler of 0 (not at all) to 10 (extremely)
Conditions Studied
Interventions
- BEHAVIORAL Weekly Voice Therapy
- BEHAVIORAL Intensive Voice Therapy
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison Voice and Swallow Clinic - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-03-13 |
| Est. Completion | 2024-03-12 |
| Phase | NA |
What the finished NCT03129880 record still lists
NCT03129880 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which Weekly Voice Therapy is the first listed.
NCT03129880 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03129880 about?
NCT03129880 is a clinical study titled "Intensive Versus Traditional Voice Therapy". The purpose of this study is to determine if there are differences in treatment outcomes between traditional voice therapy, performed weekly for a maximum of 6 weeks versus intensive voice therapy, consisting of 4-6 therapy sessions performed within one day.
What is the current status of trial NCT03129880?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-03-13. Estimated completion is 2024-03-12.
What conditions does trial NCT03129880 study?
This clinical trial studies the following conditions: Dysphonia.
What interventions are being tested in trial NCT03129880?
The interventions under investigation include: Weekly Voice Therapy (BEHAVIORAL), Intensive Voice Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03129880?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03129880 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
RECRUITING · NA
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
COMPLETED · NA
-
Silk Protein Microparticle-based Filler for Injection Augmentation
COMPLETED · NA
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI